Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 10, 2022

BUY
$223.92 - $287.77 $2.6 Million - $3.34 Million
11,600 Added 77.33%
26,600 $6.38 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $3.42 Million - $4.47 Million
12,100 Added 417.24%
15,000 $4.25 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $461,605 - $540,797
-1,900 Reduced 39.58%
2,900 $811,000
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $94,504 - $142,252
-400 Reduced 7.69%
4,800 $1.18 Million
Q3 2020

Nov 13, 2020

SELL
$264.77 - $305.71 $2.33 Million - $2.69 Million
-8,800 Reduced 62.86%
5,200 $1.48 Million
Q1 2020

May 13, 2020

SELL
$268.85 - $341.04 $16.2 Million - $20.6 Million
-60,400 Reduced 81.18%
14,000 $4.43 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $242,066 - $334,477
-1,100 Reduced 1.46%
74,400 $22.1 Million
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $8.41 Million - $9.44 Million
38,700 Added 105.16%
75,500 $17.6 Million
Q2 2019

Aug 12, 2019

BUY
$219.29 - $241.72 $241,219 - $265,892
1,100 Added 3.08%
36,800 $8.61 Million
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $5.5 Million - $8.61 Million
25,400 Added 246.6%
35,700 $8.44 Million
Q3 2018

Nov 09, 2018

SELL
$293.51 - $383.83 $3.32 Million - $4.34 Million
-11,300 Reduced 52.31%
10,300 $3.64 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $6.07 Million - $7.12 Million
21,600
21,600 $6.76 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.